ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded by Ahmed Jamaloodeen & Dylon Du Plooy on September 5, 2001 and is headquartered in Fort Lauderdale, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Protext Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Protext Pharma Inc market cap is $43.08M.
What is the 52-week high for Protext Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Protext Pharma Inc 52 week high is $0.0068 as of February 13, 2026.
What is the 52-week low for Protext Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Protext Pharma Inc 52 week low is $0.0001 as of February 13, 2026.
What is Protext Pharma Inc stock price today?
Protext Pharma Inc stock price today is $0.0048.
What was Protext Pharma Inc stock price yesterday?
Protext Pharma Inc stock price yesterday was $0.0049.
What is the Price-to-Book ratio of Protext Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Protext Pharma Inc P/B ratio is 0.1694.
What is the 50-day moving average of Protext Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Protext Pharma Inc 50-day moving average is $0.0039.